HealthTech

Seaport Therapeutics

Seaport Therapeutics raises $225M Series B

$225M
Total Raised
Series B
Latest Round
2023
Founded
100+
Employees
Boston, MA
1 min read

Quick Facts

Latest Round Size
$225M
Latest Round Date
October 2024

Seaport Therapeutics: Series B Funding Round

Seaport Therapeutics has successfully raised $225M in Series B funding.

Company Overview

Biotech developing neuropsychiatric therapies

Funding Details

The Series B round was led by Multiple investors.

Company Information

  • Headquarters: Boston, MA
  • Founded: 2023
  • Employees: 100+
  • Category: HealthTech

Investment

Seaport Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Multiple investors: Verified investor in Series B

Key Investors

Multiple investors
Lead Investor
Verified investor in Series B

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources